Morgan Stanley analyst Meta Marshall maintains 8×8 (NASDAQ:EGHT) with a Equal-Weight and raises the price target from $4.5 to $5.4.
Expert Ratings for Vertex Pharmaceuticals
Analysts have provided the following ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) within the last quarter: Bullish Somewhat Bullish Indifferent…